Natalie McEvoy is a PhD Scholar and Irish Research Council Awardee at the School of Nursing and Midwifery at the RCSI. Natalie is a Senior Clinical Research Nurse in the Department of Critical Care and Anaesthesia at the RCSI and Beaumont Hospital, Dublin. Natalie graduated with a BSc in General Nursing in 2014 from Dublin City University. She graduated from RCSI with a Postgraduate Diploma in Neuroscience Nursing in 2016, and an MSc in Neuroscience nursing in 2018. Natalie’s clinical experience is in the area of Critical Care, with a particular interest in Neuro Critical Care. Natalie is a member of the Irish association of Critical Care Nurses (IACCN) and the Irish Critical Care Research Coordinators Group (ICCRCG).Throughout the COVID-19 pandemic, Natalie has been involved in a number of ICU COVID-19 research studies, and is currently project managing and coordinating the first approved clinical trial in Ireland to test a therapy for COVID-19. This phase 2 double-blinded randomized controlled trial involves the administration of alpha-1 antitrypsin to patients with COVID-19-associated moderate to severe acute respiratory distress syndrome (ARDS). Natalie was a co-applicant on a recently funded Science Foundation Ireland (SFI) grant to prevent PPE-related skin injury in frontline healthcare workers.